136944-15-5Relevant academic research and scientific papers
Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents
Moosavi, Fatemeh,Hosseini, Razieh,Rajaian, Hamid,Silva, Tiago,Magalh?es e Silva, Diogo,Saso, Luciano,Edraki, Najmeh,Miri, Ramin,Borges, Fernanda,Firuzi, Omidreza
, p. 3235 - 3246 (2017/05/29)
Neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease, threaten the lives of millions of people and the number of affected patients is constantly growing with the increase of the aging population. Small molecule neurotrophic age
CAFFEIC ACID DERIVATIVES AND USES THEREOF
-
Paragraph 00055; 00058, (2017/10/13)
The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of tuberculosis.
Pharmaceutical composition containing slightly water-soluble drug
-
, (2008/06/13)
The orally administrable pharmaceutical compositions containing a slightly water-soluble drug, characterized by improved stability and improved absorption of the drug from digestive tract into blood. The use of the compositions of the present invention enables decrease of the dose amount of a slightly water-soluble drug, which eventually leads to alleviation of pains and side effects on the part of patients.
Lipoxygenase inhibitor
-
, (2008/06/13)
A lipoxygenase inhibitor comprising as active ingredient a substituted styrene derivative having a radical of the general formula STR1 wherein X denotes a hydroxyl group or a lower alkoxy group and q is an integer of 2 or 3, and containing carbon atoms in
